Isis Pharmaceuticals Inc raised $31,000,000 on , from Astrazeneca.

Get alertedif Isis Pharmaceuticals Inc gets funded!
Amount:$31,000,000
Company:
Investors:
Industry:Biotechnology
Country:
State:
City:
United States
California
Carlsbad
Key people:C. Frank Bennett (Senior Vice President of Research)
Christopher K. Mirabelli (Founder,Senior Research and Development Positions)
Yasunori Kaneko (Senior Vice President and CFO)
Paul Klingenstein (Board Member, Board of Directors)
Elizabeth L. Hougen (Senior Vice President, Finance and Chief Financial Officer)
Brett P. Monia (Senior Vice President of Antisense Drug Discovery)
Spencer R. Berthelsen (Board of Directors)
Patrick R. O’neil (Senior Vice President, Legal and General Counsel)
Richard S. Geary (Senior Vice President of Development)
Shawn Swaney (management positions)
Data sources:
www.fiercebiotech.com - Isis grabs $31M in quick AstraZeneca cash during busy deal-making round - FierceBiotech
Description:
Isis Pharmaceuticals Inc raised 31M in funding. Isis Pharmaceuticals Inc specializes in Medical devices and equipment. The date of the transaction is December 11th, 2012.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!